Jiangsu Hengrui Pharmaceuticals Co.,Ltd (SHA:600276)
56.88
+0.58 (1.03%)
At close: Mar 18, 2026
SHA:600276 Market Cap
SHA:600276 has a market cap or net worth of 376.79 billion as of March 18, 2026. Its market cap has increased by 32.21% in one year.
Market Cap
376.79B
Enterprise Value
336.93B
Revenue
30.98B
Ranking
n/a
PE Ratio
49.03
Stock Price
56.88
Market Cap Chart
Since October 20, 2000, SHA:600276's market cap has increased from 2.58B to 376.79B, an increase of 14,523.75%. That is a compound annual growth rate of 21.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 373.09B | -5.73% |
| Dec 31, 2025 | 395.76B | 35.60% |
| Dec 31, 2024 | 291.86B | 1.48% |
| Dec 29, 2023 | 287.60B | 17.03% |
| Dec 30, 2022 | 245.74B | -23.94% |
| Dec 31, 2021 | 323.08B | -45.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sichuan Biokin Pharmaceutical | 112.45B |
| Zhejiang NHU Company | 107.91B |
| Yunnan Baiyao Group Co.,Ltd | 101.86B |
| Shenzhen Salubris Pharmaceuticals | 65.31B |
| Shanghai Fosun Pharmaceutical (Group) | 63.13B |
| Huadong Medicine | 63.07B |
| China Resources Sanjiu Medical & Pharmaceutical | 49.06B |
| Beijing Tongrentang | 41.39B |